Discover our top-rated, regulated brokers. Compare platforms, fees and features, and explore the latest broker offers.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
61% of retail CFD accounts lose money. Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you should not expect to be protected if something goes wrong. Take 2 mins to learn more at https://etoro.tw/44JRWLY
CFDs and FX are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
AskTraders may earn a commission when you click through to a broker.
Shell (NYSE: SHEL) (LON: SHEL) has attracted takeover interest from rivals ExxonMobil (NYSE: XOM) and LyondellBasell (NYSE: LYB) for a swath of its underperforming U.S. chemicals assets, according…
easyJet (LON: EZJ), the London-listed budget airline and holidays group, and its takeover suitor Apollo have agreed to push back the deadline for publishing the formal scheme document…
Vistry Group (LON: VTY), the UK housebuilder focused on mixed-tenure and affordable housing, saw its shares soar after Homes England, the government’s housing and regeneration agency, confirmed it…
London shares are trading firmer on Tuesday, with the FTSE 100 up 0.3% and the FTSE 250 adding 0.2%, tracking a broadly positive tone across Europe. The DAX,…
Gulf Keystone Petroleum (LON: GKP), the independent oil producer and operator of the Shaikan Field in Iraqi Kurdistan, surged in early trade on Tuesday after half-year results showed…
Shares in Melrose Industries (LON: MRO) climbed on Tuesday, up around 2.6% to 474p, after the aerospace and automotive group provided an update on the incident at its…
Tialis Essential IT (LON: TIA), the AIM-listed IT managed services provider, reported a sharp fall in first-half revenue and profit earlier today, as delayed customer orders and the…
Shares in AstraZeneca (LON: AZN) edged higher on Tuesday, August 25, 2026, after the pharmaceutical giant announced it had successfully priced a €2.55 billion bond offering through its…
Equity Development told investors in a note on Monday that the sell-off in Hunting (LON: HTG) shares following the oilfield services group’s first-half results went too far, reiterating…
Rio Tinto’s (NYSE: RIO) U.S.-listed shares dipped on Monday after Morgan Stanley initiated coverage with an Underweight rating and a $90 price target, arguing the mining giant’s risk/reward…
Aviva (LON: AV.) shares have been on a strong run through the last 18 months, climbing from lows near 450p to a 52-week high of 740.6p in mid-August…
Shares in Diageo (LON: DGE) have staged a notable recovery after a punishing sell-off earlier this year drove the FTSE 100 drinks giant to its lowest levels in…
Shares of Unite Group (LON: UTG) edged marginally lower into Monday’s close after Barclays downgraded the UK student-accommodation landlord to Underweight from Equal Weight, alongside a reduced price…
London’s main indices opened Monday on the back foot, with the FTSE 100 down 0.1% and the FTSE 250 broadly flat as investors weighed a fresh escalation in…
Haleon (LON: HLN), the consumer health group behind Sensodyne, Panadol and Advil, has had its price target raised by broker Jefferies to 410p from 400p after half-year results…
Shares in Tracsis (LON: TRCS) rose on Monday morning, up around 4.7% to 335p, after the transport technology group confirmed trading for the year to 31 July 2026…
GSK plc (LSE/NYSE: GSK) shares slipped slightly in early Monday trading, even as the pharmaceutical giant unveiled two regulatory milestones for its oncology and hepatology portfolios. The US…
Temporary power supplier Aggreko is preparing to file for a New York stock market listing that could value the company at around $20 billion, or £14.7 billion, according…
Defence and pharma names dominate the FTSE 100’s technical picture heading into next week, with three stocks showing setups worth watching. BAE Systems has been the standout momentum…
Jefferies has trimmed its price target on Weir Group to 3,515p from 3,555p, though the broker maintained its Buy rating on the FTSE 100 mining equipment maker, according…
Sign up to our free Morning Markets email, every weekday before the open.
Español
Melayu
Deutsch
